Calliditas Therapeutics Competitors and Similar CompaniesClear all

Calliditas Therapeutics's competitors and similar companies include moksha8 Pharmaceuticals, Ocular Therapeutix, Merz North America and Servier.

	Calliditas Therapeutics Calliditas Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments in orphan indications.	moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.	Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.	Merz North America Merz North America is a specialty healthcare company dedicated to the development and marketing of products for physicians and patients.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.
Founding Date	Founding Date 2004	Founding Date 2006	Founding Date 2006	Founding Date 1908	Founding Date 1954
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech mental health pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Stockholm, SE HQ Archamps, FR Stockholm, SE Stockholm, SE Plan Les Ouates, CH Hoboken, US New York, US	Locations Berwyn, US HQ Ciudad De México, MX	Locations Bedford, US HQ Bedford, US Bedford, US	Locations Frankfurt am Main, DE HQ Raleigh, US	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more
Employees	Employees 2221% increase	Employees 370	Employees 16740% increase	Employees 2,4801% increase	Employees 12,9983% increase
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) N/A	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr1.2b (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $52m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr60.5m (FY, 2023)	Cost of goods N/A	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr1.2b (FY, 2023)	Gross profit N/A	Gross profit $45.4m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (kr466.2m) (FY, 2023)	Net income N/A	Net income ($265.9m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 33.2m	Total funding raised $ 224.1m	Total funding raised $ 73.3m	Total funding raised N/A	Total funding raised N/A